Aspen Neuroscience Revenue and Competitors

Location

#2259

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Aspen Neuroscience's estimated annual revenue is currently $18.3M per year.(i)
  • Aspen Neuroscience's estimated revenue per employee is $155,000
  • Aspen Neuroscience's total funding is $76.5M.

Employee Data

  • Aspen Neuroscience has 118 Employees.(i)
  • Aspen Neuroscience grew their employee count by 16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Aspen is developing enabling technologies for patient-specific induced pluripotent stem cell-based therapies.

keywords:N/A

$76.5M

Total Funding

118

Number of Employees

$18.3M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aspen Neuroscience News

2022-04-13 - Aspen to commence screening study for Parkinson's disease treatment

The Trial-Ready Cohort Study will offer data for the planned Phase I/IIa trial of ANPD001. Aspen Neuroscience has announced plans to commence a...

2022-04-06 - Aspen Neuroscience Launches First Patient Screening Study for ...

SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing induced pluripotent stem cell...

2021-05-05 - Aspen Neuroscience Announces Promotion of Andres Bratt-Leal, PhD, to Senior Vice President of Research & Development

SAN DIEGO, May 5, 2021 /PRNewswire/ -- Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Andres Bratt-Leal, PhD, has been promoted to Senior Vice President of Research & Devel ...

2020-04-03 - Aspen Neuroscience Raises $70 Million Led By OrbiMed

Aspen Neuroscience, a biotechnology company developing the first autologous neuron replacement therapy for treating Parkinson’s announced it raised $70 million Aspen Neuroscience, a biotechnology company developing the first autologous neuron replacement therapy for treating Parkinson’s disease ...

2020-04-01 - Aspen Neuroscience Gets $70M

San Diego-based Aspen Neuroscience, a biotechnology company developing treatments for Parkinson disease, said it has raised $70M in a Series A funding round. The funding was led by OrbiMed, and also included ARCH Venture Partners, Frazier Healthcare Partners, Domain Associates, Section 32, and S ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.6M14331%N/A
#2
$41.9M1500%N/A
#3
$42.7M1531%N/A
#4
$21.7M155-69%$401.5M
#5
$7.5M156-1%N/A